stockrowBoston Scientific Corporation
BSX Healthcare Medical Devices
Boston Scientific Corporation’s revenue for fiscal 2025 (year ended December 2025) was $20.1 billion, up 19.9% from fiscal 2024.
- Revenue
- +1.44%
- EPS
- −21.6%
- Free cash flow
- −25.3%
- Total debt
- +3.04%
Quarter to September 2026, against a year earlier
Follow BSX
Alert me
Boston Scientific Corporation (BSX) Current ratio
Boston Scientific Corporation's current ratio at the end of the quarter to 30 September 2026 was 1.4×, down 0.3× from fiscal 2025 (1.6×). Over the past ten years it has ranged from 0.7× (fiscal 2017) to 1.8× (fiscal 2020); the current reading is higher than 91% of that period. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.6× | 49.51% |
| FY2024 | 1.1× | (18.11%) |
| FY2023 | 1.3× | (12.82%) |
| FY2022 | 1.5× | 2.48% |
| FY2021 | 1.5× | (18.72%) |
| FY2020 | 1.8× | 88.31% |
| FY2019 | 1.0× | 26.90% |
| FY2018 | 0.8× | 12.57% |
| FY2017 | 0.7× | (25.14%) |
| FY2016 | 0.9× | (36.78%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 1.4× | 10.05% |
| Jun 2026 | 1.2× | (34.72%) |
| Mar 2026 | 1.9× | 17.50% |
| Dec 2025 | 1.6× | 7.21% |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| EW Edwards Lifesciences Corporation compare | 4.6× |
| SYK Stryker Corporation compare | 2.2× |
| MDT Medtronic PLC compare | 2.1× |
| STE STERIS plc compare | 2.1× |
| DXCM DexCom, Inc. compare | 1.7× |
| ABT Abbott Laboratories compare | 1.4× |
| BSX Boston Scientific Corporation | 1.4× |
| PHG Koninklijke Philips N.V. compare | 1.3× |
| GEHC GE HealthCare Technologies Inc. compare | 1.3× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on BSX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement